Market news

Lupin Launches Darunavir Tablets in the US.

Major  Pharma Player Lupin Limited (Lupin) today announced the launch of Darunavir Tablets, 600 mg and 800 mg, to market a generic equivalent of Prezista® Tablets of Janssen Products, LP.

Darunavir Tablets, 600 mg and 800 mg (RLD Prezista®) had estimate Annual sales of USD 308 million in the U.S. (IQVIA MAT March 2023).

Similar Posts